4th Annual Glomerular Disease Symposium:An Update on Disease Mechanisms and Management 2026

The 4th Annual Washington University Glomerular Disease Symposium is planned and implemented by physicians from the Division of Nephrology and the Division of Anatomic and Molecular Pathology. This live, in-person course is designed primarily for practicing nephrologists and nephrology trainees, and may also be of interest to rheumatologists, internal medicine physicians and trainees, advanced practice providers, and nephrology nurses.

This 16-hour program provides a comprehensive update on the latest advances in the pathogenesis, diagnosis, and treatment of glomerular diseases. The format includes lectures, panel discussions, interactive breakout workshops, and Q&A sessions to promote active learning. The goal of this activity is to enhance knowledge, skills strategy, performance, and patient care.

1. Evaluate and apply current evidence based diagnostic and therapeutic approaches across major glomerular diseases (e.g., IgA nephropathy, lupus nephritis, ANC Aassociated GN, podocytopathies, complement mediated disease, and onconephrology cases) to optimize patient management.
2. Differentiate disease specific treatment strategies by interpreting clinical trial data, guideline updates, and expert panel recommendations to support individualized, precision based care decisions in glomerular disease.
3. Integrate multidisciplinary insights (nephrology, pathology, genetics, and emerging therapeutics) to improve diagnostic accuracy and selection of targeted therapies in complex glomerular disease presentations.
4. Critically analyze evolving controversies in glomerular disease management (e.g., immunosuppression intensity, timing of intervention, use of plasma exchange, and genetic testing) and apply structured clinical reasoning to realworld patient cases.

This is a continuing medical education activity intended for healthcare providers.

Registration will be available until on September 9, 2026, 12:00pm Central Time Zone.  After this time, please register on-site.

Residents & Fellows please email Lindsay Widaman [email protected] for information to register at no charge. Verification of your training status maybe requested. 

Fees include enrollment, continuing education credits, online educational materials, daytime self-parking (paid registrants only), continental breakfast, lunch, refreshment breaks, and dinner reception.

Employees of industry (e.g., pharmaceutical and device companies), please email [email protected] for information regarding attendance at this course.

Registration/Payment Policy: Your full payment in advance completes your registration and ensures your enrollment in this course. To inquire about the availability to register on-site, please contact the CME office.

Cancellations: Registration fee, less $50 administrative charge, is refundable if cancellation is received in writing by emailing [email protected] by August 28, 2026. No refunds will be made on cancellation requests received after that date. Registration fees are not transferrable.

Minimum and Maximum Enrollments Have Been Established.

In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available for this Activity:

American Medical Association (AMA)
Washington University School of Medicine in St. Louis designates this {Activity Format} for a maximum of 16.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The cancellation cut-off dates and fees are specific to each course. Refer to the cancellation policy on the individual course page. Please send cancellation requests to [email protected].

WashU Medicine CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets or hotel penalties.

This meeting is conducted in accordance with the requirements of the Americans with Disabilities Act (ADA) and applicable regulations.
Individuals who require accommodations to participate are encouraged to submit a written request as early as possible, but no later than ten (10) business days prior to the seminar date, to allow sufficient time to arrange appropriate accommodations. Requests received after this deadline will be reviewed and a good faith effort will be made to provide reasonable accommodations to the extent feasible.

Suggested Hotel Accommodations: 
Doubletree by Hilton St. Louis Forest Park 
Adjacent to the conference center:
4550 Forest Park Ave., St. Louis, MO 63110
Make your hotel reservations directly with the hotel:
Ask for the Washington University Visitor rate.
Online at  Book your hotel Enter Code #3209101 under “special rate corporate”
By phone at 314-256-7777

Home 2 Suites by Hilton St. Louis/ Forest Park
920 S. Taylor Avenue, St. Louis, MO 63110
Make your hotel reservations directly with the hotel:
Online: Book your hotel
By phone: Reservations phone number is 314-531-4446

The Chase Park Plaza Royal Sonesta St. Louis
212 N Kingshighway Blvd, St. Louis, MO 63108
Make your hotel reservations directly with the hotel:
Online: Book your hotel
By phone: Reservations phone number is 314-633-3300

Please Note: Washington University is not responsible for airline, hotel reservations or any other travel expenses. Please confirm registration acceptance prior to purchase of nonrefundable or penalty airline tickets.

Transportation:
•    Taxis from the airport are approximately $40.
•    Uber and Lyft are also available.
•    MetroLink runs from the airport to the Medical Center
     (Central West End Station) for approximately $4.00.

Washington University School of Medicine in St. Louis School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Washington University School of Medicine in St. Louis adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Tingting Li, MD, MSCI
Professor of Medicine
Washington University in St. Louis
St. Louis, MO

Course Director, Faculty

Grant or research support-Alpine Immune Sciences Inc|Grant or research support-Calliditas Therapeutics|Grant or research support-Dimerix|Grant or research support-ENYO Pharma|Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Vertex Pharmaceuticals Inc|Other relevant financial or material interests-Amgen (*)|Other relevant financial or material interests-Calliditas Therapeutics (*)|Other relevant financial or material interests-Curio Science, LLC (*)|Other relevant financial or material interests-GlaxoSmithKline/GSK|Other relevant financial or material interests-Novartis (*)|Other relevant financial or material interests-Travere Therapeutics Inc (*)|Other relevant financial or material interests-Vera Therapeutics (*)

Jonathan Barratt, PhD
University of Leicester
Leicester, United Kingdom

Faculty

Duvuru Geetha, MD
Professor of Clinical Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

Faculty

Raymond K Hsu, MD
Associate Professor of Medicine
University of California San Francisco
San Francisco, CA

Faculty

Anuja Java, MD
Associate Professor of Medicine
Washington University
St. Louis, MO

Faculty

Grant or research support-Novartis Institutes for Biomedical Research/NIBR|Other relevant financial or material interests-Alexion Pharmaceuticals Inc|Other relevant financial or material interests-Apellis Pharmaceuticals, Inc.|Other relevant financial or material interests-Novartis Pharmaceuticals Corporation|Other relevant financial or material interests-Alexion Pharmaceuticals Inc (*)|Other relevant financial or material interests-Apellis Pharmaceuticals, Inc. (*)

Alfred H Kim, MD, FACR
Associate Professor
Washington University School of Medicine
Saint Louis, MO

Faculty

Consulting Fee-ABBVIE (Relationship has ended)|Consulting Fee-AMGEN (Any division) (Relationship has ended)|Grant or research support-AstraZeneca (Any division)|Consulting Fee-AURINIA PHARMA U.S., INC.|Grant or research support-BRISTOL-MYERS SQUIBB|Grant or research support-CRISPR Therapeutics|Consulting Fee-Exagen Diagnostics|Consulting Fee-GENENTECH (Relationship has ended)|Consulting Fee-GLAXOSMITHKLINE|Consulting Fee-Hinge Bio (Relationship has ended)|Consulting Fee-Invivyd|Consulting Fee-Kymera Therapeutics (Relationship has ended)|Consulting Fee-Kypha|Royalties or Patent Beneficiary-Kypha|Consulting Fee-Miltenyi Biomedicine (Relationship has ended)|Grant or research support-NOVARTIS PHARMACEUTICALS|Honoraria-The Rheumatology Education Group|Honoraria-UpToDate|Consulting Fee-Zenas BioPharma

Brad Rovin, MD, FASN, FACP
Professor of Medicine
Ohio State University Wexner Medical Center
Columbus, OH

Faculty

Ladan Zand, MD
Program Director to Glomerular Diseases Fellowship
Mayo Clinic
Rochester, MN

Faculty

Nidia Messias, MD
Professor, Pathology & Immunology
Washington University in St. Louis
St. Louis, MO

Other Planning Committee Member

Other relevant financial or material interests-Novartis (*)

Reena Gurung, MD
Assistant Professor of Medicine
Washington University in St. Louis
St. Louis, MO

Peer Reviewer

Nothing to disclose